.
MergerLinks Header Logo

New Deal

New Deal

Announced

Medios to acquire NewCo Pharma for €125m.

Financials

Edit Data
Transaction Value£104m
Consideration TypeOrdinary Shares, Cash
Capital Owned-
Capital Bid For100%
EV/Sales0.8x
EV/EBITDA-
Share Price Premium-
One Off Charge-
Medios

bidder

Medios

Newco Pharma

target

Newco Pharma

Sources

Edit

Press Release

Medios - 

Tags

Edit

Private

Medical Equipment

Majority

Domestic

Germany

Friendly

infusion solutions

Single Bidder

Pending

Acquisition

Synopsis

Edit

Medios, a pharmaceutical company, agreed to acquire NewCo Pharma, a provider of patient-specific infusion solutions, for €125m. This enables Medios to significantly expand its business activities in the segment of patient-specific therapies throughout Germany.

Service Providers

Dealmakers (5)

Christoph Erhard

Christoph Erhard

Senior Consultant at Kekst CNC
Deal Bio
Total Deals
7/
Total Value
£105M
Claudia Nickolaus

Claudia Nickolaus

Head of Investor & Public Relations at MEDIOS AG
Deal Bio
Total Deals
1/
Total Value
£105M
Roland Leithaeuser

Roland Leithaeuser

Director at Kekst CNC
Deal Bio
Total Deals
24/
Total Value
£13,902M
Christopher Deifuss

Christopher Deifuss

Senior Associate at Kekst CNC
Deal Bio
Total Deals
3/
Total Value
£2,235M
Matthias Gärtner

Matthias Gärtner

CFO at MEDIOS AG
Deal Bio
Total Deals
2/
Total Value
£213M

Search a database of more than 250,000 verified dealmakers

Receive automated updates on global transactions

Follow the activity, relationships and transactions of top dealmakers

No credit card required
Register nowSign up with LinkedIn

© COPYRIGHT 2024 MERGERLINKS LIMITED.

ALL RIGHTS RESERVED.

15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.

CONTACT US